Docking studies and model development of tea polyphenol proteasome inhibitors: Applications to rational drug design
- 4 September 2003
- journal article
- research article
- Published by Wiley in Proteins-Structure Function and Bioinformatics
- Vol. 54 (1), 58-70
- https://doi.org/10.1002/prot.10504
Abstract
Previously, we demonstrated that natural and synthetic ester bond-containing green tea polyphenols were potent and specific non-peptide proteasome inhibitors. However, the molecular mechanism of inhibition is currently unknown. Here, we report that inhibition of the chymotrypsin activity of the 20S proteasome by (−)-epigallocatechin-3-gallate (EGCG) is time-dependent and irreversible, implicating acylation of the β5-subunit's catalytic N-terminal threonine (Thr 1). This knowledge is used, along with in silico docking experiments, to aid in the understanding of binding and inhibition. On the basis of these docking experiments, we propose that (−)-EGCG binds the chymotrypsin site in an orientation and conformation that is suitable for a nucleophilic attack by Thr 1. Consistently, the distance from the electrophilic carbonyl carbon of (−)-EGCG to the hydroxyl group of Thr 1 was measured as 3.18 Å. Furthermore, the A ring of (−)-EGCG acts as a tyrosine mimic, binding to the hydrophobic S1 pocket of the β5-subunit. In the process, the (−)-EGCG scissile bond may become strained, which could lower the activation energy for attack by the hydroxyl group of Thr 1. This model is validated by comparison of predicted and actual activities of several EGCG analogs, either naturally occurring, previously synthesized, or rationally synthesized. Proteins 2003.Keywords
This publication has 35 references indexed in Scilit:
- Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitorJournal of Molecular Biology, 2001
- Structural Bases for Inhibitor Binding and Catalysis in Polyamine Oxidase,Biochemistry, 2001
- Pharmacological proteasome inhibitors and their therapeutic potentialExpert Opinion on Therapeutic Patents, 2000
- The Protein Data BankNucleic Acids Research, 2000
- Structure of 20S proteasome from yeast at 2.4Å resolutionNature, 1997
- Mechanistic Studies on the Inactivation of the Proteasome by LactacystinJournal of Biological Chemistry, 1996
- Tea Consumption and Lung Cancer Risk: A Case‐Control Study in Okinawa, JapanJapanese Journal of Cancer Research, 1995
- Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallateCancer Letters, 1995
- Effect of (−)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell linesCancer Letters, 1992
- Binding-catalysis relationship in α-chymotrypsin action as revealed from reversible inhibition study of phenylalkylboronic acidsFEBS Letters, 1972